Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs) EQUITY
$64.84
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | TEVA Avg Daily Volume: 4,830,300
Last Update: 09/02/15 - 4:02 PM EDT
Volume: 0
YTD Performance: 12.75%
Open: $0.00
Previous Close: $64.84
52 Week Range: $47.36 - $72.31
Oustanding Shares: 839,348,282
Market Cap: 53,030,024,457
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 10 9 10
Moderate Buy 2 2 0 0
Hold 6 5 8 9
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.88 1.86 2.11 2.10
Latest Dividend: 0.29
Latest Dividend Yield: 1.81%
Dividend Ex-Date: 08/18/15
Price Earnings Ratio: 42.40
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
42.40 21.30 24.17
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.03% 24.36% 63.82%
GROWTH 12 Mo 3 Yr CAGR
Revenue -0.20 0.11 0.03
Net Income 142.80 0.10 0.03
EPS 138.50 0.15 0.05
Earnings for TEVA:
EBITDA 6.00B
Revenue 20.27B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $1.28 $1.26 $5.30 $5.45
Number of Analysts 19 19 21 22
High Estimate $1.33 $1.45 $5.45 $6.26
Low Estimate $1.22 $1.16 $5.15 $4.98
Prior Year $1.32 $1.31 $5.07 $5.30
Growth Rate (Year over Year) -3.39% -3.62% 4.60% 2.68%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
There is building consensus around a September rate hike.

Jensen's Morning Musings Real Money Pro($)

I'm happy as always to be standing in for Doug Kass on the Daily Diary.
Bullish
Jul 28, 2015 | 7:22 AM EDT
TEVA was upgraded to Outperform, BMO Capital said. $80 price target. Allergan deal makes the company a generic leader. 

Tread Carefully in the Market Real Money Pro($)

This week could easily bring additional selling.
And we are raising our price target on AGN.
And four other things you need to know now.
Two tech companies in Jim Cramer's charitable trust report as well.
Pharmaceutical firm's chart shows a likely move to the upside.

Columnist Conversations

As has been talked about the last few days, the Chinese markets are closed, so most markets in Asia are enjoyi...
Been having very interesting exchanges on Twitter (started last night) about McDonald's -- some with folks at ...
Nice to have a solid day in the market after yesterday big decline especially a rally that held its strength i...
In mid July WHR held key support near the $160.00 area after blowing out support near its 200 day moving ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.